NASDAQ · IRTC
Healthcare · Medical - Devices
$126.17
Up+$2.80 (+2.27%)
Updated Nov 3, 2026, 11:09 AM
SID Score
5.0/10
Composite research score
Smart Money
58/100
Neutral
Price performance · IRTC
1M range · 0 trading sessions · Daily adjusted prices
IRTC does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning IRTC.
Company
Market Activity
Research & News
IRTC research
Company profile and research snapshot.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 16, 2026 | Piper Sandler | Overweight | — |
| Oct 6, 2026 | Wells Fargo | Overweight | — |
| Oct 6, 2026 | Freedom Capital Markets | Buy | — |
| Oct 5, 2026 | Needham | Buy | — |
| Aug 18, 2026 | Wells Fargo | Overweight | — |
No generated briefing is available yet.
Yahoo · Oct 29, 2026
IRHYTHM HLDGS (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo · Oct 28, 2026
iRhythm Holdings has reported 24% annual revenue growth over the last two years and recently moved into positive free cash flow, signaling improved operating efficiency and stronger commercial traction for its wearable cardiac monitoring services. The combination of rapid top line expansion and a shift to cash generation is drawing interest despite a high forward P/E, as it suggests iRhythm Holdings is converting demand for its Zio platform into a more self-funding business model. Next is an...
Yahoo · Oct 18, 2026
Price target updates for iRhythm Holdings now reflect a slightly lower fair value of US$171.33 compared with the prior US$178.93. Analysts link this adjustment to fresh views on execution risk around the VitalConnect acquisition, the timing of Zio MCT, and a wider spread between optimistic and cautious expectations after Q2. As you read on, you will see how these evolving targets help you track the shifting narrative around iRhythm Holdings and what to watch next. Analyst Price Targets don't...
Yahoo · Oct 18, 2026
iRhythm Holdings (IRTC) has drawn fresh attention after recent trading left the share price at US$108.66, with the stock down 3% over the past month and 2% over the past 3 months. Short-term trading has been choppy, with a 7 day share price return of 1.84% but a year to date share price decline of 37.99%. That weaker momentum aligns with a 1 year total shareholder return that has fallen 40.23%, even though the 5 year total shareholder return is still up 59.79% for iRhythm Holdings. Compare...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning IRTC.
